“showed a trend”

Among 48 patients receiving 3L therapy, regorafenib showed a trend toward improved OS over sorafenib (HR, 0.33; 95% CI, 0.11 to 1.02; p=0.051), supported by restricted mean survival time analysis (p=0.028).

The number of recurrences showed a trend for an association with additional resection ( p = 0.051).

The RSS showed a trend towards a significant increase in the weeks before exacerbation (p = 0.051).

Regarding gender, the distribution showed a trend ( χ 2 (5) = 11.02, p = .051, Cramer's V = .21).

Compared to the AD cases, the PD cases showed a trend of reduced noradrenergic cell density (− 61%, P = 0.051, uncorrected), but no significant difference in noradrenergic fiber load ( P = 0.124) (Fig. 3 ).

The pre-determined obesity parameters for females showed a trend towards an inverse association between trabecular bone volume and change in body weight (−0.365 6, P = 0.051 1), but a significant negative correlation between trabecular bone volume and the fold change in fat mass (−0.378 7, P = 0.042 8) (Fig.

AQLQ scores showed a trend of improvement in Group 1 ( P = 0.051), and improvements in Group 3 ( P < 0.001) in patients treated with omalizumab at Week 24 ( Fig. 1 C).

Although the difference did not reach statistical significance, bevacizumab showed a trend toward improved survival (p=0.051, Figure 5B ).

The variant rs112076606 (A/G) showed a trend toward a significant association with both BMIC and UIC ( P = 0.051 and P = 0.081).

However, serum P levels showed a trend toward a difference between the high and medium tertiles (−17.1 ± 7.3%, p = .051) ( Figure S2 ).

Although the intervention group showed a trend toward lower incidence, the difference was not statistically significant (RR = 0.31, 95% CI: 0.09 to 1.01; Z = −1.95, P = 0.0510).

Log TILL showed a trend to be higher in the amnestic VCI group versus normal cognition (mean difference 0.709, 95% CI −0.003–1.421, SE 0.2995, P = 0.051).

By univariate survival analyses of all cases, high expression of CD47 alone showed a trend of association with reduced RFS ( p = 0.051; Figure 2A ).

Additionally, GNL reactivity showed a trend toward association with more aggressive tumour phenotypes and poorer prognosis ( p = 0.051; Figure S5 D ).

In terms of age-related differences, in the YA subgroup, pFear was positively correlated with left S1 activation (r = 0.56, p = 0.011, coefficient of determination = 0.31) and the association between pFear and right S1 showed a trend of significance (r = 0.44, p = 0.051, coefficient of determination = 0.19).

Plasma Appetite-Related Gut Peptides The LED pdr intervention showed a trend towards a decrease plasma GLP-1 (Week, p = 0.051) ( Table 4 ), without a significant difference between dietary groups (Protein×Week, p = 0.176; CHO×Week, p = 0.675; Protein×CHO×Week, p = 0.600) ( Supplementary Table S1 ).

The decrease was statistically significant in the LFD group ( p = 0.002), while the traditional IBS diet group showed a trend toward improvement ( p = 0.051).

Model comparison showed no effect of imagery type of pages for the French texts (Estimate=0.014, t =0.718, χ 2 =0.510, p =0.475), while it showed a trend for the Davis texts (Estimate=-0.029, t =-2.046, χ 2 =3.800, p =0.051).

Among the time-domain measures, high HR max –HR min [odds ratio (OR), 0.579; 95% confidence interval (CI), 0.405–0.828; p = 0.003], SDNN (OR, 0.725; 95% CI, 0.578–0.909; p = 0.005), STD (OR, 0.044; 95% CI, 0.004–0.559; p = 0.016), and RMSSD (OR, 0.858; 95% CI, 0.755–0.975; p = 0.019) were associated with a low risk of PD, independent of age and sex, whereas pNN50 showed a trend of negative association with the risk of PD (OR, 0.784; 95% CI, 0.614–1.001; p = 0.051).

Independent predictors included ECOG 0 and thoracic spine V 5 < 57.3%; planning target volume < 210 cm 3 showed a trend toward association ( p = 0.051).

5571 ± 3524 ms 2 /Hz, p = 0.002) and showed a trend toward higher values during SSM (58,941 ± 91,929 ms 2 /Hz, p = 0.051).

Comparison with primary EFTR showed a trend toward lower technical success (81.5% vs. 100.0%, P = .051), but no differences in recurrence or AEs.

Finally, adjusted Vit D to body weight showed a trend of positive relationship with pelvis BMD ( r = .37, P = .051; n = 28).

The abundance of Sneathia sanguinegens in untreated patients was also higher than in controls, and this difference showed a trend toward statistical significance ( p = 0.051).

Multivariate analysis showed that PIK3R1 expression status was an independent predictor of MFS in the total population (p = 0.0013), whereas PIK3CA mutation status only showed a trend in the ERBB2+ population (p = 0.051).